Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma

201093 citationsJournal Article

Authors

Ira J. Dunkel · Memorial Sloan Kettering Cancer Center

Yasmin Khakoo · Memorial Sloan Kettering Cancer Center

Nancy A. Kernan · Memorial Sloan Kettering Cancer Center

Timothy R. Gershon · Memorial Sloan Kettering Cancer Center

Stephen W. Gilheeney · Memorial Sloan Kettering Cancer Center

David Lyden · Memorial Sloan Kettering Cancer Center

Suzanne L. Wolden

Abstract

Intensive multimodality therapy including high-dose chemotherapy with autologous hematopoietic stem cell rescue was curative for the majority of patients with stage 4a metastatic retinoblastoma treated. The contribution of external beam radiation therapy is unclear.

Topics & Keywords

Ocular Oncology and Treatments Neuroblastoma Research and Treatments Brain Metastases and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pediatric Blood & Cancer

Volume 55, Issue 1, pp. 55-59

DOI: 10.1002/pbc.22504

Field-Weighted Citation Impact: 3.88